Categories
Archives
Category Archives: Gene therapy
Genetic Technologies Files Quarterly Activities Report and ASX Appendix 4C for Quarter Ended December 31, 2011
MELBOURNE, AUSTRALIA– – Genetic Technologies Limited today announced it has filed its Quarterly Activities Report and Appendix 4C for period ending December 31, 2011 in accordance with the ASX.Total cash …Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&p=genetic+therapy&eo=UTF-8
Posted in Gene therapy
Comments Off
Entering into the clinic with an intracerebral gene therapy product / Karen Aiach, Project Manager, – Video
01-02-2012 05:22 Specific challenges of avant-garde therapies Authorities/sponsors: being concomitantly on a learning curve Translational research: key success factors Case study: SAF-301 Continue reading
Posted in Gene therapy
Tagged a-learning-curve, authorities, being-concomitantly, key-success, learning-curve, saf, specific-, translational
Comments Off
Apes Trailer/Gene Therapy – Video
26-01-2012 21:26 Short Trailer on the history and applications of Gene Therapy in the modern medical scene. Written and directed by Thenmozhi Soundaranagaran Score by Keith Jackson Continue reading
Posted in Gene therapy
Tagged and-applications, and-directed, keith-jackson, medical-scene-, modern, score, short, the-history, the-modern, thenmozhi, thenmozhi-soundaranagaran, therapy, trailer-on-the
Comments Off
Retraction: Acharya CR, et al. Gene expression signatures, clinicopathological features, and individualized therapy in …
Chaitanya R. Acharya, MS; David S. Hsu, MD, PhD; Carey K. Continue reading
Posted in Gene therapy
Tagged alabama, chapel-hill, durham-veterans, editor, genome-sciences, medical-center, medicine, nature, nature-medicine, north
Comments Off
Amsterdam Molecular Therapeutics Announces European Commission Delays Decision on Glybera® Marketing Authorisation and …
AMSTERDAM, January 30, 2012 /PRNewswire/ –Amsterdam Molecular Therapeutics (Euronext: AMT – News), a leader in the field of human gene therapy, was informed on Friday January 27, 2012 after business hours that … Continue reading
Posted in Gene therapy
Tagged 2012-after, amsterdam-molecular, amt, business-hours, friday, friday-january, informed-on-friday, the-field-
Comments Off
Cardium Presents New Generx Findings at 2012 Annual Gene and Cell Therapy Forum
SAN DIEGO, Jan. 30, 2012 /PRNewswire/ – Cardium Therapeutics (NYSE Amex: CXM) today reported on new insights and confirmatory preclinical study results on the Generx (Ad5FGF-4) angiogenic therapy product … Continue reading
Posted in Gene therapy
Tagged and-confirmatory, angiogenic-therapy, cardium-therapeutics, cxm, diego, generx, new-insights, nyse, product, results-on-the, san, study-results, therapeutics, today-reported
Comments Off
Fibrocell Science, Inc. Announces Recognition for LAVIV™ (azficel-T) at The 2012 Cell & Gene Therapy Forum, Washington …
EXTON, Pa.–(BUSINESS WIRE)– Fibrocell Science, Inc. (OTCBB: FCSC.OB – News), a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announces that the June 2011 FDA approval of LAVIV™ (azficel-T) for the improvement of the appearance of “smile line” wrinkles was named the #3 top story of 2011 in cell and gene therapy and regenerative medicine at The 2012 Cell & Gene Therapy Forum in Washington, D.C. Continue reading
Posted in Gene therapy
Tagged chairman, fibrocell, fibrocell-science, focused-on-the, health, healthcare, improvement, information, june, laviv, science, skin, therapy-forum
Comments Off
New discovery paves way for genetic screening test
Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors.Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&p=genetic+therapy&eo=UTF-8
Posted in Gene therapy
Comments Off
Study Pinpoints Genetic Variation that Raises Risk of Serious Complication Linked to Osteoporosis Drugs
Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors.Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&p=genetic+therapy&eo=UTF-8
Posted in Gene therapy
Comments Off
NHS 'must back genetic medicine'
Putting genetic testing at the heart of the NHS could herald a "revolution" in diagnosing, treating and preventing disease, according to the government's genetics adviser.Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&p=genetic+therapy&eo=UTF-8
Posted in Gene therapy
Comments Off
Study pinpoints genetic variation that raises a risk linked to bisphosphonates
Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors. The discovery paves the … Continue reading
Posted in Gene therapy
Comments Off
Genetic variation that raises risk of serious complication linked to osteoporosis drugs identified
Researchers have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors.Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&p=genetic+therapy&eo=UTF-8
Posted in Gene therapy
Comments Off
Gene therapy is a 'disruptive science' ready for commercial development
The time for commercial development of gene therapy has come. Patients with diseases treatable and curable with gene therapy deserve access to the technology, which has demonstrated both its effectiveness and feasibility, says James Wilson, MD, PhD, Editor-in-Chief of Human … Continue reading
Posted in Gene therapy
Comments Off
Characterization of an HIV-Targeted Transcriptional Gene-Silencing RNA in Primary Cells
Human Gene Therapy , Vol. 0, No. 0. (Source: Human Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
Posted in Gene therapy
Comments Off
Decreasing Disease Severity in Symptomatic, Smn?/?;SMN2+/+, Spinal Muscular Atrophy Mice Following scAAV9-SMN Delivery
Human Gene Therapy , Vol. 0, No. 0. (Source: Human Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
Posted in Gene therapy
Comments Off
Long-Term Expression of Human Coagulation Factor VIII in a Tolerant Mouse Model Using the ?C31 Integrase System
Human Gene Therapy , Vol. 0, No. 0. (Source: Human Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
Posted in Gene therapy
Comments Off
Gene Therapy for Retinitis Pigmentosa Caused by MFRP Mutations: Human Phenotype and Preliminary Proof of Concept
Human Gene Therapy , Vol. 0, No. 0. (Source: Human Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
Posted in Gene therapy
Comments Off
Successful Gene Therapy in Utero for Lethal Murine Hypophosphatasia
Human Gene Therapy , Vol. 0, No. 0. (Source: Human Gene Therapy) MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
Posted in Gene therapy
Comments Off
Improving TCR Gene Therapy for Treatment of Haematological Malignancies
Adoptive immunotherapy using TCR gene modified T cells may allow separation of beneficial Graft versus tumour responses from harmful GvHD. Improvements to this include methods to generate high avidity or high affinity TCR, improvements in vector design and reduction in … Continue reading
Posted in Gene therapy
Comments Off